The antiviral molnupiravir, a major breakthrough in the treatment of COVID-19

The pharmaceutical Merck recently announced that its antiviral drug molnupiravir is halving the hospitalizations and mortality of patients most at risk of developing severe forms of COVID-19. Download the column

Share this content!

Recent Articles

Column Archives

Column Keywords